Home
>
National Drug Code (NDC)
>
Sennazon
Sennazon - 76518-100-08 - (Sennosides A and B)
Drug Information of Sennazon
| Product NDC: | 76518-100 |
| Proprietary Name: | Sennazon |
| Non Proprietary Name: | Sennosides A and B |
| Active Ingredient(s): | 8.8 mg/15mL & nbsp; Sennosides A and B |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SYRUP |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Sennazon
| Product NDC: | 76518-100 |
| Labeler Name: | Bayshore Pharmaceuticals LLC [FL] |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part334 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20120501 |
Package Information of Sennazon
| Package NDC: | 76518-100-08 |
| Package Description: | 237 mL in 1 BOTTLE, PLASTIC (76518-100-08) |
NDC Information of Sennazon
| NDC Code | 76518-100-08 |
| Proprietary Name | Sennazon |
| Package Description | 237 mL in 1 BOTTLE, PLASTIC (76518-100-08) |
| Product NDC | 76518-100 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Sennosides A and B |
| Dosage Form Name | SYRUP |
| Route Name | ORAL |
| Start Marketing Date | 20120501 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Bayshore Pharmaceuticals LLC [FL] |
| Substance Name | SENNOSIDES A AND B |
| Strength Number | 8.8 |
| Strength Unit | mg/15mL |
| Pharmaceutical Classes |
